Patents by Inventor Matthew P. YATES

Matthew P. YATES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fatty acid modified human epidermal growth factor
    Patent number: 11358994
    Abstract: The disclosure provides for new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. Method of using such agents to treatment Short Bowel Syndrome (SBS) are also described.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: June 14, 2022
    Assignee: Saint Louis University
    Inventors: Marvin J. Meyers, David C. Wood, Stacy D. Arnett, Matthew P. Yates, Peter G. Ruminski
  • FATTY ACID MODIFIED HUMAN EPIDERMAL GROWTH FACTOR
    Publication number: 20200190157
    Abstract: The disclosure provides for new epidermal growth factor (EGF)-based reagents that have been modified by fatty acid conjugation. Method of using such agents to treatment Short Bowel Sydnrome (SBS) are also described.
    Type: Application
    Filed: July 25, 2018
    Publication date: June 18, 2020
    Applicant: Saint Louis University
    Inventors: Marvin J. MEYERS, David C. WOOD, Stacy D. ARNETT, Matthew P. YATES, Peter G. RUMINSKI